Articles

  • Jun 10, 2024 | jinsa.org | Zac Schildcrout

    | Share: Despite growing Chinese investment in Israel’s economy, China has clearly demonstrated that its interest in Israel is purely instrumental and subordinate to its global ambitions of supplanting the United States on the world stage. Since October 7, China has calculated it can better advance that strategic agenda by siding with Hamas and Iran.

  • May 30, 2024 | jinsa.org | Zac Schildcrout

    The war between Israel and Hamas has been intensely scrutinized. Questions about the Israel Defense Forces’ strategy, operations, legality of conduct, concern for mitigating harm to civilians, and provision of humanitarian assistance are being raised and actively debated from the public square to international organizations and governments.

  • May 29, 2024 | jinsa.org | Zac Schildcrout

    JINSA hosted a webinar discussing the latest regional developments in Israel’s multi-front war against Iran’s proxies, including the recent IDF airstrike in Rafah that killed two high-ranking Hamas members and inadvertently killed several civilians, ongoing ground maneuvers in Rafah, and increasing attacks from Hezbollah in Lebanon.

  • May 23, 2024 | jinsa.org | Zac Schildcrout

    | Share: Amid concern among some Israeli leaders over the lack of a “day after” plan for Gaza and as the IDF continues its limited operations against Hamas in Rafah and northern Gaza, JINSA hosted a webinar to discuss the latest developments in the Israel-Hamas war.

  • May 8, 2024 | jinsa.org | Matthew Kenney |Zac Schildcrout

    | Share: According to multiple media reports, the Biden administration has made a deliberate decision to pause certain U.S. arms shipments to Israel. This move is apparently meant to send a message of U.S. disapproval of Israel’s plan to conduct major combat operations in Rafah and to pressure a change in Israeli policy.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →